Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
Dividend
|
Strong Performer, Getting Expensive
2132.5000
4.80
(
0.23
%)
NSE
Sep 12, 2025
15:31 PM
67.19% Gain from 52W Low
Volume:
615.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
13 Feb 2023, 12:00AM
Dividend
2132.50
0.23%
Financial leverage/tax outweighs operational improvements
Neutral:
Glenmark Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 420
Motilal Oswal
Glenmark Pharmaceuticals Ltd. has gained
49.93%
in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - September 12, 2025
The Baseline |
12 Sep 2025, 04:39PM
Market closes higher, Hindustan Copper announces a Rs 2,000 crore capex
Trendlyne Marketwatch |
12 Sep 2025, 04:00PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020